Logo image of XBOT.CA

REALBOTIX CORP (XBOT.CA) Stock Fundamental Analysis

TSX-V:XBOT - TSX Venture Exchange - CA75604K1075 - Common Stock - Currency: CAD

0.39  -0.04 (-9.3%)

Fundamental Rating

1

Overall XBOT gets a fundamental rating of 1 out of 10. We evaluated XBOT against 20 industry peers in the Machinery industry. XBOT has a bad profitability rating. Also its financial health evaluation is rather negative. XBOT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year XBOT has reported negative net income.
In the past year XBOT has reported a negative cash flow from operations.
XBOT had negative earnings in 4 of the past 5 years.
In the past 5 years XBOT always reported negative operating cash flow.
XBOT.CA Yearly Net Income VS EBIT VS OCF VS FCFXBOT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -244.21%, XBOT is doing worse than 90.00% of the companies in the same industry.
XBOT has a worse Return On Equity (-424.95%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA -244.21%
ROE -424.95%
ROIC N/A
ROA(3y)-62.89%
ROA(5y)-29.3%
ROE(3y)-84.55%
ROE(5y)-42.13%
ROIC(3y)N/A
ROIC(5y)N/A
XBOT.CA Yearly ROA, ROE, ROICXBOT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

XBOT's Gross Margin of 36.99% is fine compared to the rest of the industry. XBOT outperforms 75.00% of its industry peers.
XBOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XBOT.CA Yearly Profit, Operating, Gross MarginsXBOT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

3

2. Health

2.1 Basic Checks

XBOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XBOT has been increased compared to 1 year ago.
The number of shares outstanding for XBOT has been increased compared to 5 years ago.
Compared to 1 year ago, XBOT has a worse debt to assets ratio.
XBOT.CA Yearly Shares OutstandingXBOT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
XBOT.CA Yearly Total Debt VS Total AssetsXBOT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

XBOT has an Altman-Z score of 4.30. This indicates that XBOT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.30, XBOT belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
A Debt/Equity ratio of 0.29 indicates that XBOT is not too dependend on debt financing.
XBOT's Debt to Equity ratio of 0.29 is fine compared to the rest of the industry. XBOT outperforms 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 4.3
ROIC/WACCN/A
WACC8.9%
XBOT.CA Yearly LT Debt VS Equity VS FCFXBOT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

XBOT has a Current Ratio of 0.75. This is a bad value and indicates that XBOT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.75, XBOT is doing worse than 80.00% of the companies in the same industry.
XBOT has a Quick Ratio of 0.75. This is a bad value and indicates that XBOT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of XBOT (0.56) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.56
XBOT.CA Yearly Current Assets VS Current LiabilitesXBOT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

1

3. Growth

3.1 Past

XBOT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.25%.
Looking at the last year, XBOT shows a very strong growth in Revenue. The Revenue has grown by 209.93%.
EPS 1Y (TTM)-131.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)209.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%166.08%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year88.24%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XBOT.CA Yearly Revenue VS EstimatesXBOT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 1M 2M 3M
XBOT.CA Yearly EPS VS EstimatesXBOT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 0 -0.02 -0.04

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XBOT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XBOT.CA Price Earnings VS Forward Price EarningsXBOT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XBOT.CA Per share dataXBOT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for XBOT!.
Industry RankSector Rank
Dividend Yield N/A

REALBOTIX CORP

TSX-V:XBOT (8/11/2025, 7:00:00 PM)

0.39

-0.04 (-9.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)08-14 2025-08-14/bmo
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners41.54%
Ins Owner ChangeN/A
Market Cap77.98M
Analysts80
Price Target0.71 (82.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-28.53%
Min Revenue beat(2)-42.04%
Max Revenue beat(2)-15.02%
Revenue beat(4)0
Avg Revenue beat(4)-46.33%
Min Revenue beat(4)-79.41%
Max Revenue beat(4)-15.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-46.67%
Revenue NY rev (1m)-43.86%
Revenue NY rev (3m)-43.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.16
P/FCF N/A
P/OCF N/A
P/B 13.03
P/tB 18.3
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.02
BVpS0.03
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -244.21%
ROE -424.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.99%
FCFM N/A
ROA(3y)-62.89%
ROA(5y)-29.3%
ROE(3y)-84.55%
ROE(5y)-42.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.56
Altman-Z 4.3
F-Score2
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)209.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%166.08%
Revenue Next Year88.24%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-73.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-64.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.35%
OCF growth 3YN/A
OCF growth 5YN/A